Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Bruno

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Molecular Biosystems|January 5, 2013
Predicting cancer drug mechanisms of action using molecular network signaturesJustin R Pritchard, Peter M Bruno, Michael T Hemann, et al.
Chembiochem : a European Journal of Chemical Biology|July 6, 2016
The Potent Inhibitory Effect of a Naproxen-Appended Cobalt(III)-Cyclam Complex on Cancer Stem CellsPaul B Cressey, Arvin Eskandari, Peter M Bruno, et al.
Journal of the American Chemical Society|November 13, 2015
A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-ChemotherapySamuel G Awuah, Yao-Rong Zheng, Peter M Bruno, et al.
Journal of the American Chemical Society|September 18, 2013
Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathwaysKogularamanan Suntharalingam, Timothy C Johnstone, Peter M Bruno, et al.
Angewandte Chemie (International Ed. in English)|January 26, 2016
Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug ComplexesJanine N Boodram, Iain J Mcgregor, Peter M Bruno, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2012
Defining principles of combination drug mechanisms of actionJustin R Pritchard, Peter M Bruno, Luke A Gilbert, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2016
Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbationChristian J Braun, Peter M Bruno, Max A Horlbeck, et al.
Inorganica Chimica Acta|November 8, 2016
Mechanistic Studies of the Anticancer Activity of An Octahedral Hexanuclear Pt(II) CageYao-Rong Zheng, Kogularamanan Suntharalingam, Peter M Bruno, et al.
Dalton Transactions (Cambridge, England : 2003)|October 25, 2016
The breast cancer stem cell potency of copper(ii) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticlesArvin Eskandari, Janine N Boodram, Paul B Cressey, et al.
Journal of the American Chemical Society|September 24, 2014
A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complexKogularamanan Suntharalingam, Wei Lin, Timothy C Johnstone, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Molecular Biosystems|January 5, 2013
Predicting cancer drug mechanisms of action using molecular network signaturesJustin R Pritchard, Peter M Bruno, Michael T Hemann, et al.
Chembiochem : a European Journal of Chemical Biology|July 6, 2016
The Potent Inhibitory Effect of a Naproxen-Appended Cobalt(III)-Cyclam Complex on Cancer Stem CellsPaul B Cressey, Arvin Eskandari, Peter M Bruno, et al.
Journal of the American Chemical Society|November 13, 2015
A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-ChemotherapySamuel G Awuah, Yao-Rong Zheng, Peter M Bruno, et al.
Journal of the American Chemical Society|September 18, 2013
Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathwaysKogularamanan Suntharalingam, Timothy C Johnstone, Peter M Bruno, et al.
Angewandte Chemie (International Ed. in English)|January 26, 2016
Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug ComplexesJanine N Boodram, Iain J Mcgregor, Peter M Bruno, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2012
Defining principles of combination drug mechanisms of actionJustin R Pritchard, Peter M Bruno, Luke A Gilbert, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2016
Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbationChristian J Braun, Peter M Bruno, Max A Horlbeck, et al.
Inorganica Chimica Acta|November 8, 2016
Mechanistic Studies of the Anticancer Activity of An Octahedral Hexanuclear Pt(II) CageYao-Rong Zheng, Kogularamanan Suntharalingam, Peter M Bruno, et al.
Dalton Transactions (Cambridge, England : 2003)|October 25, 2016
The breast cancer stem cell potency of copper(ii) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticlesArvin Eskandari, Janine N Boodram, Paul B Cressey, et al.
Journal of the American Chemical Society|September 24, 2014
A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complexKogularamanan Suntharalingam, Wei Lin, Timothy C Johnstone, et al.
Pageof 3